The estimated Net Worth of Sarah Condella is at least $7.67 Million dollars as of 30 April 2024. Sarah Condella owns over 102 units of Exact Sciences stock worth over $4,655,817 and over the last 4 years Sarah sold EXAS stock worth over $3,011,475.
Sarah has made over 33 trades of the Exact Sciences stock since 2021, according to the Form 4 filled with the SEC. Most recently Sarah sold 102 units of EXAS stock worth $6,135 on 30 April 2024.
The largest trade Sarah's ever made was exercising 13,102 units of Exact Sciences stock on 11 June 2021 worth over $199,937. On average, Sarah trades about 3,029 units every 33 days since 2021. As of 30 April 2024 Sarah still owns at least 72,611 units of Exact Sciences stock.
You can see the complete history of Sarah Condella stock trades at the bottom of the page.
Sarah's mailing address filed with the SEC is C/O EXACT SCIENCES CORP., 5505 ENDEAVOR LANE, MADISON, WI, 53719.
Over the last 21 years, insiders at Exact Sciences have traded over $118,141,352 worth of Exact Sciences stock and bought 191,930 units worth $1,451,887 . The most active insiders traders include Kevin T Conroy, Edwin M Jr Kania, and Maneesh Arora. On average, Exact Sciences executives and independent directors trade stock every 12 days with the average trade being worth of $1,667,056. The most recent stock trade was executed by Brian Baranick on 5 August 2024, trading 2,712 units of EXAS stock currently worth $173,893.
exact sciences is a molecular diagnostics company focused on colorectal cancer. the company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. stool-based dna (sdna) technology is included in the colorectal cancer screening guidelines of the american cancer society and the u.s. multi-society task force on colorectal cancer. for more information on exact sciences' noninvasive colon cancer screening test, visit cologuardtest.com
Exact Sciences executives and other stock owners filed with the SEC include: